Literature DB >> 11555477

Is infective blood donation missed without screening for antibody to hepatitis B core antigen and/or hepatitis B virus DNA?

A Mühlbacher, D Zdunek, W Melchior, U Michl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555477     DOI: 10.1046/j.1423-0410.2001.00086.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  7 in total

1.  Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study.

Authors:  Mutiat K Ogunfemi; Hannah O Olawumi; Abdulfatai B Olokoba; Modu B Kagu; Sikiru A Biliaminu; Kabir A Durowade; Idayat A Durotoye; Akeem O Shittu
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

2.  The Role of anti-HBc IgM in Screening of Blood Donors.

Authors:  H Kumar; P K Gupta; M Jaiprakash
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria.

Authors:  Margaret Oluwatoyin Japhet; Olufisayo Adeyemi Adesina; Emmanuel Donbraye; Moses Olubusuyi Adewumi
Journal:  Virol J       Date:  2011-11-10       Impact factor: 4.099

4.  Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran.

Authors:  Farhad Khorami; Seyed Alireza Sobhani; Parivash Davoudian; Ebrahim Khajeh
Journal:  Electron Physician       Date:  2013-08-01

5.  Prevalence of hepatitis B seromarkers and hepatitis C antibodies in blood donors in Basra, Iraq.

Authors:  Ali Al-Rubaye; Ziad Tariq; Laith Alrubaiy
Journal:  BMJ Open Gastroenterol       Date:  2016-01-04

6.  Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia.

Authors:  Desalegn Admassu Ayana; A Mulu; A Mihret; B Seyoum; A Aseffa; R Howe
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  Occult Hepatitis B Virus Infection and Its Risks of Cryptic Transmission in Southern Ethiopia.

Authors:  Gizachew Beykaso; Andargachew Mulu; Mirutse Giday; Nega Berhe; Markos Selamu; Dawit Hailu; Tilahun Teklehaymanot
Journal:  Infect Drug Resist       Date:  2022-02-24       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.